TrialCardiovascular drugs and therapy2024

Efficacy and Safety of Inclisiran in Patients with Polyvascular Disease: Pooled, Post Hoc Analysis of the ORION-9, ORION-10, and ORION-11 Phase 3 Randomized Controlled Trials.

Wolfgang Koenig et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.